A 56 -kDa protein isolated from the mucus of the European sea hare Aplysia punctata shows a preferential toxicity to autonomously growing transformed mammalian cells. Cell death induced by this protein differs from both apoptosis and necrosis. The cytotoxic effects are irreversible and become apparent at nanomolar concentrations in a cell type -dependent manner. In contrast, injection of micromolar concentrations into mice is tolerated without apparent negative consequences. Microsequencing of the 56 -kDa protein released a peptide sequence whose corresponding nucleotide sequence was used as probe to screen A. punctata RNA -based cDNA and to select cDNA clones encoding polypeptides comprising the target peptide. Two closely related cDNA were detected. The cDNA encoding a polypeptide 558 aa in length was considered to reflect a bona fide clone encoding the cytotoxic protein. Its protein -coding section was recloned in vectors suitable for expression in Escherichia coli, in mammalian cells, and in insect cells, respectively. The E. coli -expressed polypeptide was biologically inactive. Transfected mammalian cells expressed a cytotoxic factor and died thereof as if treated with the genuine cytotoxic protein.
Introduction
Marine organisms represent an essentially unexploited reservoir for genes and metabolic products of potential biological and / or pharmacological interest [1] [2] [3] . So far, literature on natural products derived from marine organisms is dominated by low -molecular -weight compounds characterized by cytotoxicity. A number of such natural drugs are either clinically applied or under evaluation as potential anticancer drugs [1] [2] [3] . In contrast, reports on exploitable genes from marine organisms and their products are rare. The green fluorescent protein from the jellyfish Aequorea victoria may serve as an example for a gene of basic biological interest, which is widely used in biotechnology as reporter for studies on gene expression and protein localization in living cells [ 4 ] . The latter technology is also applied in the present study.
Sea hares appear to represent another species producing high -molecular -weight gene products of interest. Originally, the toxicity of the mollusc Aplysia was found to be due to lowmolecular -weight metabolic substances deriving from algal diet [ 5 ] . However, cytolytic, antimicrobial, and antifungal activities could be detected in biochemical isolates of high molecular weight from the sea hares Aplysia kurodai, A. juliana, and Dolabella auricularia. Accordingly, it was suggested that these organisms might produce water -soluble gene -expressed biopolymers of pharmacological interest [ 5, 6 ] . Furthermore, these biochemical investigations suggest that sea hares produce a number of closely related glycoproteins of different sizes and with different biological activities. First attempts to characterize these proteins on the sequence level led to the molecular cloning of one A. kurodai -derived cDNA, which showed significant sequence identities with the cDNA encoding a protein produced by the giant African snail Achatina fulica [7] . However, a clear correlation of the protein encoded by the cloned A. kurodai cDNA with any biological activity is missing. This is most likely due to the fact that the biologically active molecules are glycoproteins and that recombinant expression in Escherichia coli results in biologically inactive proteins.
The potential pharmacological value of Aplysia -derived proteins stimulated our approach to identify cytotoxic activities of the European sea hare A. punctata on the sequence level. A bioassay -guided fractionation of the secreted mucus of albumen glands released a 56 -kDa glycoprotein, which showed cytotoxic effects on autono-mously growing cells in nanomolar concentrations. Based on its cytotoxicity, its possible effects on neoplasia, and its origin Aplysia, the protein was termed cyplasin. Microsequencing released an internal peptide whose corresponding nucleotide sequence was used as probe for the molecular cloning of two cDNA encoding closely related A. punctata proteins. A cytotoxic recombinant form of one of these variants is expressed in mammalian and in insect cells underlining the validity of the cloning approach and providing the basis for a potential application of this bioactive molecule.
Materials and Methods

Biochemical Isolation of Cyplasin
Mucus of albumen glands of the sea hare A. punctata can be obtained from animals during the spawning season when they come to the shore ( around April on Ile d'Yeu ) . By gently squeezing the animal, the mucus ( approximately 2.5 ml ) is excreted as purple fluid, forming a gel when exposed to air. It is immediately diluted ( 1:1, vol / vol ) with phosphatebuffered saline ( PBS; 150 mM NaCl, 10 mM NaH 2 PO 4 , pH 7.2 ) and placed at 48C. After 2 to 3 hours, the mixture becomes completely soluble. This step is followed by centrifugation at 10,000Âg, 15 minutes, 48C, to remove debris. The supernatant can be frozen and kept at À 808C without loss of activity. For further purification, the mucus is dialysed against 1000 vol of 50 mM MOPS, 1 mM dithioerythreitol, 0.5 mM EDTA, 5 mM KCl, pH 7.2 for 24 hours at 48C. Protein fractions containing the cytotoxic activity were isolated by fractionated precipitation with ammonium sulphate. Cytotoxic activity was detected in precipitates collected between 33% / 50% ( pellet 1 ) and 50% / 66% ( pellet 2 ) saturation, respectively. Most of the cytotoxic activities were usually found in pellet 1. For cytotoxicity tests, pellets were dissolved in 300 l of PBS, dialysed against the buffer described above. The most active fractions comprised protein ( s ) migrating as an essentially single band on a sodium dodecyl sulfate polyacrylamide gel electrophoresis ( SDS -PAGE ) gel ( Figure 1 ).
Identification of the SGDYILIASYAD Peptide in the Fraction of Cytotoxic Protein ( s )
Material used for the microsequencing procedure was further purified by gel filtration ( G -200 column; SigmaAldrich, Taufkirchen, Germany ) in a buffer comprising 50 mM MOPS, 1 mM dithioerythreitol, 0.5 mM EDTA, 5 mM KCl, at pH 7.2. The dialyzed and lyophilized efflux was submitted to SDS -PAGE and blotted to a PVDF membrane ( ProtoBlot; Applied Biosystems, Weiterstadt, Germany ) . Sections containing the region of interest were analysed by microsequencing procedures performed by WITA ( Berlin, Germany ) .
Cytotoxicity Test
Aliquots from each pellet, dissolved in 300 l of PBS, were tested for their toxic effects on autonomously growing cells. The term ''autonomously growing cells'' is used for all cells capable of proliferating in vitro, in contrast to cells proliferating within an organism. Routine tests were performed using the kangaroo rat cell line PtK2 and the human cell line HeLa. 4Â10 4 cells were seeded in 24 -well plates containing 500 l of medium per well resulting in about 50% confluency after 24 hours. At this time, undiluted aliquots of the redissolved pellet ( s ) ( 5 l ) were added and cell cultures in parallel wells were supplemented with aliquots ( 5 l) of serial dilutions.
Characterization of Cell Death Induced by Genuine Cyplasin
Morphological alterations of cells undergoing cyplasininduced death were recorded by light microscopy. In addition, permeability changes of the plasma membranes were investigated by incubating the cyplasin -treated cells with the nonmembrane permeant compound H33257 ( Sigma -Aldrich ) , 0.5 g / ml, or propidium iodide ( Boehringer Ingelheim, Ingelheim, Germany ) , 1 g / ml. Staining of nuclei was considered as indication for pathological permeability changes associated with necrosis or the final stages of apoptosis. For the visualization of the actin cytoskeleton, cells were treated with cyplasin in cell medium at 378C for the times indicated, washed in prewarmed PBS, and fixed in ice -cold ethanol at À 188C for 10 minutes on ice. After several washes with PBS, cells were treated for 10 minutes in 0.5% bovine serum albumin ( BSA ) in order to reduce unspecific staining and incubated in FITC -phalloidin ( Molecular Probes, Leiden, the Netherlands ) , diluted 1:300 in 0.5% BSA / PBS, for 45 minutes at room temperature. The unbound phalloidin was removed by several washes with PBS and the cells were viewed in a fluorescence microscope using the appropriate filters ( ZEISS Axiovert 405 ) . To differentiate the apoptotic form of death, cyplasin -treated cells were incubated in 5 g / ml FITC -labeled Annexin V ( Boehringer Ingelheim ) for 20 minutes in Ca 2 + -containing buffer and the presence of a potential phosphatidyl serineAnnexin complex was evaluated by fluorescence microscopy using appropriate filters [ 8 ] . For control, apoptosis was induced in cells by incubation with 0.2 g / ml staurosporine for 3 hours. This treatment induced a clear translocation of phosphatidylserine to the outer face of the plasma membrane, thus becoming accessible to the FITC -Annexin [ 9 ] ; the concentration of staurosporine, however, was sufficiently low to prevent the parallel staining of cell nuclei with propidium iodide.
A. punctata cDNA Total RNA was isolated from albumen glands of the sea hare A. punctata by means of the Qiagen RNA isolation kit. The Clontech SMART II polymerase chain reaction ( PCR ) cDNA synthesis kit ( K1052 -1, Clontech, Heidelberg, Germany ) was used to convert 100 ng amounts of total RNA into cDNA. First strand synthesis was primed with the modified oligo -dT included in the kit and primer extension was performed with the recommended RNase H À point mutant reverse transcriptase ( Superscript II; Invitrogen, Groningen, the Netherlands ) . The SMART II oligo inducing the template switch at 5 0 ends was included in the first strand reaction.
These reactions and PCR amplifications of first strand cDNA by means of the modified oligo ( dT ) and SMART II primers were performed according to the instructions of the producer of the kit.
Molecular Cloning of cDNA Encoding Proteins Comprising the Peptide SGDYILIASYAD Amplified cDNA was used as a template and PCR reactions were primed with combinations of specific primers corresponding to the search sequence and with nonspecific primers, e.g., modified oligo -dT and SMART II, respectively. Amplification products was recloned in a pBluescript -derived T -overhang vector and sequenced. The validity of these sequences was verified by PCR reactions primed with oligo deoxynucleotides corresponding to sequences upstream and downstream of the specific SGDYILIASYAD -encoding primer. These probe -independent products contained the nucleotide sequence encoding the peptide SGDYILIASYAD. Sequences found upstream of SGDYILIASYAD -encoding sequence were unique, except for several base exchanges discussed in the text. In contrast, two 3 0 end sequences differing in length could be detected ( L and S ).
Fusion and Expression Constructs
The protein -coding sections were PCR -amplified with primers placing suitable restriction sites to the 5 0 and 3 0 ends of the amplification products. Following digestion with the corresponding restriction endonucleases, the products were either directly cloned into the expression vectors pcDNA3 ( Invitrogen; for expression in mammalian cells ) , pQE30 ( Qiagen, Hilden, Germany; for expression in E. coli ) , pIZ / V5 -His ( Invitrogen; for expression in insect cells ) , or fused with the EGFP -encoding cDNA ( Clontech ) prepared in the XhoI/NotI sites of the pBluescript vector. Excision of the EGFP -tagged fragments and recloning in appropriate sites of the pcDNA3 vector or the pIZ / V5 -His vector resulted in the corresponding cyplasin -EGFP expression constructs suitable for expression of fluorescently labeled fusion proteins in mammalian and insect cells, respectively.
Transfections and Recombinant Protein Expression E. coli M15 cells were transformed with the pQE30 plasmids containing the cyplasin -L -and cyplasin -Sencoding inserts in frame with the His tag of the vector. The expressed His -tagged proteins were isolated by means of Ni -NTA agarose according to the protocol supplied by Qiagen.
Mammalian cells were transfected with the pcDNA3 plasmids containing either EGFP -tagged or nontagged cyplasin -L -and cyplasin -S -encoding inserts by means of the Effectene transfection kit ( Qiagen ) . Cells transfected with constructs containing the insert encoding cyplasin -L -EGFP or cyplasin -L -EGFP could not survive longer periods. However, supernatants of such cultures contained the cytotoxic factor described in the text.
SF9 cells were transfected with the pIZ / V5 -His plasmids containing either EGFP -tagged or nontagged cyplasin -Lencoding inserts using, in addition, the Effectene transfection kit ( Qiagen ) . In contrast to mammalian cells, transfected insect cells survived. Expression was followed either by fluorescence microscopy of living cells or by testing of cytosolic extracts for the presence of a cytotoxic factor.
Stably Transfected SF9 Cells for Large -Scale Production of Cyplasin -L -EGFP SF9 cells transfected with the plasmid pIZ / V5 -Hiscyplasin -L -EGFP were grown for 3 months as semiattached cells at 268C in TNM -FH insect medium ( Applichem, Darmstadt, Germany ) supplemented with 10% fetal calf serum, 5 mM Glutamax ( Life Technologies, Karlsruhe, Germany ) , and 100 g / ml zeocin ( Invitrogen ) . The cell cultures were diluted 1:3 at 4 -day intervals. The original transfection efficiency was approximately 10%; after a 3 -month period, 5% of the cells remained fluorescent. The latter fraction was considered to be stably transfected. Cells of this fraction were separated by means of a fluorescenceactivated cell sorter ( Becton -Dickinson, Heidelberg, Germany ) . Following a second sorting performed after 4 weeks, the resulting culture could be grown in spinner cultures up to several litres and more than 90% of these cells expressed cyplasin -L -EGFP fusion protein.
Recovery of the Cytotoxic Factor from SF9 Cells Stably Expressing Cyplasin -L -EGFP
The EGFP -tagged cyplasin -L is not secreted into the medium of SF9. Routinely, 1 to 2Â10 8 stably transfected SF9 cells were washed by suspension and centrifugation ( 1000Âg, 3 minutes ) , once in PBS, and once in 50 mM MES, 1 mM EDTA, 5 mM KCl, 0.1% mercaptoethanol, pH 6.0. They were homogenized in 5 ml of the latter buffer.
Homogenization and all subsequent steps were performed at 48C. A protease inhibitor cocktail ( Roche Diagnostics, Mannheim, Germany ) was present throughout the purification procedure. The homogenate was centrifuged ( 100,000Â g, 60 minutes ) , and the supernatant was applied to a DEAE Cellulose column ( DE52; Sigma -Aldrich ) that had been equilibrated with the buffer described above. The column was washed extensively with the buffer used for equilibration followed by application of a NaCl gradient ( 0 to 200 mM ) . Eluted fractions were tested for the presence of the cytotoxic factor by addition of 100 l of each fraction to indicator cells ( PtK ) growing in 500 l of culture medium. If present, cytotoxic effects were observed after about 5 hours. Factorcontaining fractions were eluted between 60 and 80 mM NaCl. Fractions with these characteristics were considered as ''standard'' extracts, and used for other biological tests.
Identification of Cyplasin -L -EGFP in Cytotoxic Extracts
Isolated from Stably Transfected SF9 Cells Protein fractions isolated as described above and exhibiting cytotoxic activity were concentrated and separated by 12.5% SDS -PAGE. Two identical samples ( including a protein standard ) were separated on the same gel. One section of the gel was stained using a silver -staining procedure; the other section was electroblotted ( semidry blotting apparatus; Biometra, Gö ttingen, Germany ) to a PVDF transfer membrane ( Westran, Schleicher, and Schuell, Dassel, Germany ) . Buffer composition was 3.03 g of boric acid, 200 ml of methanol, 800 ml of H 2 O, pH 9.0. Following blocking with BLOTTO [ 10 ] , the membrane was incubated for 3 hours ( 268C ) with anti -GFP antibody ( ABCAM, Cambridge, UK ) diluted 1:2000 in PBS, pH 7.2, containing 0.1% BSA. After prolonged rinsing in PBS, immunodetection was performed by means of an alkaline phosphatase -coupled goat -antirabbit antibody ( Dianova, Hamburg, Germany ) , which was applied for 3 hours at 268C, diluted 1:12000 PBS, pH 7.2, containing 0.1% BSA. The blot was rinsed in PBS and placed into the staining solution consisting of 100 mM TRIS, 5 mM MgCl 2 , 0.3 mg / ml nitro blue tetrazolium, 0.15 mg / ml 5 -bromo -4 -chloro -3 -indolylphospate, pH 9.5.
Animal Experiments
DBA2 mice were injected with 300 l (10 M ) of genuine cyplasin, either in the tail vein ( group 1 ) or subcutaneously ( group 2 ) . Cyplasin had been dialysed before against a large volume of PBS for 24 hours at 48C and tested for positive cytotoxicity immediately before injection by incubating PtK cells with 10 nM cyplasin. Recombinant cyplasin was also dialysed against PBS, tested for positive cytotoxicity before injection, and 300 l was injected into the tail vein. Mice were maintained under standard conditions and observed for 4 weeks.
Other Methods
Database searches and sequence analyses were performed by means of the HUSAR program package ( DKFZ ) that is a collection of sequence analysis tools based on the GCG program package developed by GCG. For the identification of the secretory signal sequence, we applied the McGeoch scan program [ 11 ] . DNA sequencing was performed by A. Hunziker ( German Cancer Research Center ) by means of an automatic DNA sequencer, model 373A ( Applied Biosystems ) .
Results
Molecular Cloning of Cyplasin -Encoding cDNA
cDNA prepared from total RNA of the albumen gland of A. punctata comprises more than one transcript encoding the peptide SGDYILIASYAD. Two cDNA were cloned encoding proteins, which diverge significantly in their carboxy -terminal sections but which comprise the target sequence ( Figure 2 ) . One of these cDNA encodes a protein of 558 aa residues with a molecular mass of 62.4 kDa ( termed cyplasin -L ) , whereas another cDNA reflects a transcript encoding a shorter protein ( 421 aa residues, molecular mass 46.9 kDa, termed cyplasin -S ) . Moreover, PCR on total cDNA with cyplasin -L -specific primer pairs results in DNA fragments whose sequences diverge from those encoding cyplasin -L and cyplasin -S, respectively. Accordingly, mRNA appear to exist, which are neither identical with cyplasin -L nor with cyplasin -S. These sequence microheterogeneities suggest that A. punctata produces an unknown number of very similar, but not 100%, identical proteins that comprise the target sequence. On the basis of the available data, it cannot be decided whether these different mRNA and proteins derive from one single gene, e.g., by alternative splicing in combination with RNA editing, or whether there exists a cluster of very similar, but not 100%, identical genes. The N -termini start with a hydrophobic secretory signal sequence of high probability and a predicted cleavage site between aa residues 52 ( Ser ) and 53 ( Ala ) . Accordingly, the molecular masses of the mature and expectedly functional proteins amount to 57.2 and 41.6 kDa, respectively. The calculated isoelectric points of these mature proteins are 5.54 ( charge À 13 ) for cyplasin -L and 6.20 ( charge À 5 ) for cyplasin -S.
Database searches with the nucleotide sequence released similarities with two other Aplysia sequences, namely A. kurodai albumen gland mRNA for aplysianin -A precursor ( 70.9% identities, D83255 [ 12 ] ) , and Ac. fulica Ferussac mRNA for achacin ( 52.2% identities, X64584 [ 7 ] ) .
Database searches with cyplasin subsequences released the amino acid sequences of the Aplysia species mentioned above and a number of protein sequences with longer strings of local identities or homologies. All the latter sequences belong to the class of monoamine oxidases. Table 1 shows alignments of one prominent cyplasin peptide string with subsequences of eukaryotic and prokaryotic monoamine oxidases. The significance of this finding remains to be elucidated; however, it is of interest to note that database searches with this and other cyplasintypical strings released no significant hits with proteins from other classes.
Expression of Biologically Inactive Recombinants in E. coli
Recombinant expression of cyplasin -encoding cDNA sequences in the pQE / E. coli M15 system results in polypeptides, which are completely insoluble in buffers containing no detergents, and suspensions of such recombinantly expressed polypeptides could not exert any cytotoxic effect when incubated together with cultured cells ( not shown ) . This missing cytotoxic activity is suggestively due to incorrect folding and / or the absence of posttranslational modifications of the polypeptides expressed in the E. coli system.
Generation of Bioactive Recombinants in Mammalian Cells
In contrast, mammalian cells, e.g., HeLa S3 suspension cells, produce a cytotoxic factor when transfected with CMV vector -driven expression constructs specifying either cyplasin -L or EGFP -tagged cyplasin -L. This factor is not detectable in cultures of nontransfected cells nor in cultures transfected with constructs expressing the cyplasin -S version. The production of the cytotoxic factor is obvious because all cells of factor -producing cultures finally die in the typical manner that is observed when mammalian cells are treated with genuine cyplasin isolated from the mucus of A. punctata. Because only a fraction of cells in such cultures is transfected, it follows that the cytotoxic factor must be released from the producer cells with the consequence of cell death of producer and nonproducer cells. The release of the cytotoxic factor is well in agreement with the predicted secretory signal at the amino terminus of the cDNA -derived amino acid sequence ( Figure 2 ). Although this self -destructing system is not suitable to produce significant amounts of biologically active recombinants, it reveals the validity of the cDNA cloning approach and it indicates that the factor encoded by the cDNA with the longer insert shows the cyplasin -typical characteristics.
Recombinant Expression of Bioactive Cyplasin -L and Cyplasin -L to EGFP in Insect Cells
Insect cells ( e.g., SF9 ) are known to be able to perform posttranslational modifications similar to mammalian cells. Because SF9 cells proved to be much less sensitive to genuine cyplasin preparations ( not shown ) , they are especially suited to generate recombinant cyplasin in sufficient amounts for biological tests. Transfection of SF9 cells with pIZ vector -driven constructs specifying the expression of cyplasin -L or of EGFP -tagged cyplasin -L could not influence the proliferation rate of SF9 cells. Moreover, the medium of SF9 cells transfected with the construct specifying that cyplasin -L contained significant cytotoxic activity for mammalian cell cultures, which shows that the secretory signal of cyplasin -L is also functioning in insect cells.
In contrast, no cytotoxic factor was released from SF9 cells transfected with the construct specifying EGFP -tagged cyplasin -L. The cyplasin -L -EGFP fusion protein is clearly expressed in SF9 cells, as shown by EGFP -dependent fluorescence ( Figure 3 ) , but no significant amounts of the cytotoxic factor can be detected in the spent medium of spinner cultures. Interestingly, the Western blot shown in Figure 4 points to the deletion of the signal sequence in the cyplasin -L section of the fusion protein. This cleavage must occur in such a way that the truncated fusion protein remains cytosolic. Alternatively, retrograde translocation from the ER to the cytosol has to be assumed. Such retrograde translocations have already been observed in other systems before [ 13 -16 ] .
However, the cytotoxic activity of the recombinantly expressed truncated cyplasin -L is maintained when fused to EGFP. The high -speed supernatant of homogenized cyplasin -L -EGFP -expressing SF9 cells was found to contain the factor that is cytotoxic to cultured mammalian cells. Consequently, stably transfected cyplasin -L -EGFPexpressing SF9 cell lines were generated by fluorescenceactivated cell sorting, and fractions of the high -speed supernatants of such cultures contained the cyplasin -L -EGFP fusion protein ( Figure 4 ) and exhibited the biological activities shown in Figure 5 .
Characteristic Features of Cyplasin -Dependent Cytotoxicity
Proliferating mammalian cells exhibit characteristic timeand concentration -dependent morphological changes when treated with the biochemically isolated genuine cyplasin from the mucus of A. punctata ( Figure 5 ) . The cytotoxic effects of the genuine cyplasin become visible, e.g., in PtK cells, in less than 1 hour at 50 nM. For this cell line, the minimum cytotoxic cyplasin concentration is in the order of 2 nM; however, at this concentration, the cytotoxic effects appear foremost after 24 hours. Once induced, the cyplasin effect is irreversible and cell death is observed even if cyplasincontaining medium is replaced by fresh medium. Other cultured mammalian cells show lower ( human skin fibroblasts, HSF ) or even higher sensitivity ( human melanoma cells, glia cells ) ( Figure 6 ).
The morphology of cyplasin -induced cell death is specific. The cells detach from the substratum, they shrink and disjoin from each other if grown as monolayer or in clusters, and occasionally they exhibit numerous small plasma vacuoles. Morphological changes of this type can also be observed in cells undergoing apoptotic cell death; however, typical indicators for apoptosis including nuclear fragmentation and exposure of phosphatidylserine on the outer membrane are missing ( Figure 7 ) . Similar forms of cell death have been described by Sperandio et al. [ 17 ] and were termed paraptosis.
Cyplasin exerts its cytotoxic effects only on cells in interphase. Mitotic cells are still able to complete anaphase and cytokinesis at a time when most interphase cells in the same culture already show the cyplasin -typical change in morphology ( Figure 8 ) . However, following completion of mitosis, these cells also die when reentering the interphase. Neither cell permeability nor the microtubular cytoskeleton nor intracellular Ca 2 + levels are affected by cyplasin ( not shown ) . Actin fibers, on the other hand, react very sensitively to cyplasin. First signs of depolymerization appear already after 10 minutes; most of the actin cytoskeleton has disappeared after 30 minutes ( Figure 9b ) with few tangles of fibrous actin remaining around the nucleus ( cf. Figure 9c ) . After a longer incubation of these cells with cyplasin, no more fibrous actin is found in the cytoplasm, with the exception of the cortical area ( Figure 9d À f , arrows ).
Evaluation of the Bioactive Recombinant Cyplasin -L -EGFP
A thorough side -by -side comparison of the biochemically isolated genuine cyplasin and the recombinant cyplasin -L -EGFP version meets the problem that the recombinant is, at present, only available on the level of enriched extracts. Although an exact quantitation is missing, so far, it is evident that the cyplasin -L -EGFP extracted from stably transfected SF9 cells exhibits cytotoxic activity, which is very similar to that induced by the biochemically isolated genuine cyplasin. Summarizing, these results show that the molecular cloning approach released a cDNA encoding a factor exhibiting cytotoxic activity similar to that detected in the secreted mucus of A. punctata, and that the cytotoxic effect of the recombinant protein is not obliterated by its fusion to EGFP.
Target Site for Cyplasin Action
The exact mechanisms behind the cytotoxic effects of cyplasin and recombinant cyplasin are not yet elaborated. However, it is unlikely that the cells take up a protein of this size with the consequence of exerting negative intracellular influence. Long -term observations of cyplasin -treated cells indicate that the first signs of cytotoxic action occur at the outer cellular membrane, at a time when the internal cell morphology shows no anomalies. This observation suggests that cyplasin docking to the outer cellular membrane represents the trigger for a still unknown cascade of events that finally leads to cell death. This view is also in agreement with other observations. Mammalian cells transfected with expression constructs specifying cyplasin -L or EGFPtagged cyplasin -L initially survive and they are able to produce the cytotoxic factor. However, they begin to exhibit the changed morphology as soon as the cytotoxic factor becomes detectable in the spent medium. This suggests that extracellular cyplasin is cytotoxic, whereas intracellular cyplasin is rather nontoxic.
Such a hypothesis was confirmed recently when, after removal of the secretion signal in the cyplasin sequence, mammalian cells were transfected with the modified construct. These cells expressed cyplasin, but continued to proliferate. Only upon homogenisation and subsequent purification did the cytotoxicity of cyplasin become apparent, killing now even the producing cells ( Petzelt et al., unpublished ) .
Absence of In Vivo Toxicity of Cyplasin
In order to test if cyplasin showed cytotoxic effects also in vivo, either genuine or recombinant cyplasin was injected into three groups of mice. Group 1 consisted of 12 DBA2 mice, which were injected with a high concentration of cyplasin into the tail vein. The concentration used exceeded by far the concentration found to be toxic in vitro. Nevertheless, all mice survived, at least up to 4 weeks. The same result was obtained when in a second group 12 DBA2 mice were injected subcutaneously under identical conditions. They survived and no negative effects were found during the observation period. Finally, a third group ( six mice ) was injected into the tail vein using the recombinant cyplasin. Again all mice survived.
Discussion
The results support previous suggestions pointing to cytotoxic substances of high molecular weight that are produced and secreted by Aplysia species [ 5, 6 ] . Protein fractions from the secreted mucus of A. punctata show cytotoxic, and finally killing, activity when added to cells that grow independently of proliferation -controlling activities, e.g., in culture. One of these factors has been charac- terized on the peptide sequence level and it has been termed cyplasin. Interestingly, cyplasin shows a graded cytoxicity on cells in culture. It is highly cytotoxic to established cell lines, as shown for the glia cell line and PtK cells, as well as to many primary tumor cells, such as the human melanoma tested. HSFs show a significantly higher tolerance. Because other tumor cells tested are also highly sensitive ( not shown ) , it appears that cyplasin is especially cytotoxic to established cell lines and to primary tumor cells. The different response of primary human fibroblasts is probably due to the fact that these cells cannot be considered as tumor cells although growing autonomously [ 18 ] . Accordingly, cyplasin might be useful for the specific elimination of nondesired cells in an organism, such as tumor cells.
Such a view is supported by preliminary in vivo experiments. In no case was a toxic effect of the injected cyplasin found when injected in normal mice, even when high concentrations of cyplasin were used. Presently, experiments with tumor -bearing animals are in progress to increase information on such preferential tumor cell cytotoxicity.
The natural source for cyplasin is limited; hence, its recombinant production appears to be a prerequisite for its potential application as an anticancer drug. In a first step, we searched for a cDNA, which could be considered to encode the protein with an apparent molecular mass of 56 kDa, which had been isolated by the bioassay -guided fractionation procedure. Using a subsequence of this protein as probe and conventional PCR and cDNA cloning techniques, we found that more than one A. punctata transcript comprises the subsequence used as specific probe. Two cDNA encoding polypeptides with diverging carboxy -termini could be identified on the sequence level. Moreover, individual cDNA clones showed slightly diverging nucleotide sequences when PCR products were cloned, which were prepared on the basis of complete A. punctata cDNA library template and primer pairs fitting the coding regions of the cDNA identified in the first step. Actually, all individual clones investigated so far showed slightly different nucleotide sequences with the consequence of one or more amino acid exchanges in the corresponding polypeptide. It is highly unlikely that all these transcripts originate from different genes in A. punctata. Posttranslational processes like alternative splicing, differential polyadenylation, and RNA editing could result in transcripts encoding the different polypeptides.
At this stage, it is unknown whether the different polypeptides identified at the transcript level exhibit all identical functions. In this situation, it appeared worthwhile to select only one cDNA species ( encoding the protein termed cyplasin -L ) and to investigate whether this sequence could encode a cytotoxic protein. The recombinant polypeptide produced in E. coli was found to be biologically inactive. However, eukaryotic cells transfected with constructs expressing this selected cDNA or this cDNA in fusion with the EGFP -encoding nucleotide sequence produced a cytotoxic factor that was not present in nontransfected cells nor in cyplasin -S -transfected cells. Insect cells ( SF9 ) transfected with pIZ -driven expression constructs became especially useful. In this case, stably transfected cell lines could be established, which permitted the preparation of biologically active EGFP -tagged cyplasin -L in quantities sufficient to compare the biological activity of the recombinant protein with the material that can be biochemically isolated from the secreted mucus of A. punctata. The very similar morphological effects achieved by the biochemical isolate and by the recombinantly expressed protein suggest that the selected cDNA is a valid clone and that it encodes a protein presenting the cytotoxic principle of the genuine cyplasin of A. punctata. With the availability of bioactive recombinant cyplasin, it is now possible to evaluate its potential antitumor therapeutic value.
Further studies should reveal whether the cloned cDNA specifies the only cytotoxic protein among the slightly different transcripts mentioned above or whether other transcripts encode proteins that possess equal or even greater cytotoxic activity.
